AFM and type 2 diabetes mellitus: Even though the physiological properties of this hepatokine are not fully characterized, increasing evidence has shown that afamin is strongly associated with MS (12), T2DM (13), non-alcoholic fatty liver disease (NAFLD) (19) and other IR-related conditions (11, 14).